Lipophagy inducer 1
Lipophagy inducer 1 (Compound 2726.007) is a lipophagy inducer. Lipophagy inducer 1 has the primary activity of reducing lipid droplet accumulation and rescuing podocyte cell death. Lipophagy inducer 1 exerts its effects by activating lipophagy and regulating the LXR signaling pathway. Lipophagy inducer 1 can be used in the study of the treatment of diabetic nephropathy (DKD) and other diseases related to lipid metabolism disorders[1].
Product Specifications
UNSPSC
12352005
Target
Autophagy; LXR
Related Pathways
Autophagy; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Field of Research
Metabolic Disease
Smiles
O=C1N(CC)[C@H]([C@H](C)CC)CN1CCCC[C@H]2CN=C(CCCC3CCCCC3)N2
Molecular Formula
C25H46N4O
Molecular Weight
418.66
References & Citations
[1]Njeim R, et al. Novel Lipophagy Inducers as Potential Therapeutics for Lipid Metabolism Disorders. ACS Chem Biol. 2025 Jun 20;20 (6) :1406-1416.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Burkholderia cenocepacia UPF0391 membrane protein Bcenmc03_6069 (Bcenmc03_6069), partial
Recombinant Burkholderia cenocepacia UPF0391 membrane protein Bcenmc03_6069 (Bcenmc03_6069), partial
![(E/Z)-1-[4-(2-Chloroethoxyphenyl]-1,2-diphenyl-1-butene](https://cdn.genprice.uk/genprice/uk/genprice2.webp)